热门资讯> 正文

Rapport Therapeutics报告第二季度业绩

2026-08-06 02:21

Rapport Therapeutics(RAPP) 0
高盛(GS) 0

Rapport Therapeutics press release (RAPP): Q2 net Loss was $56.6M, as compared to $26.7M for the prior year period.
RAPP expects that cash, cash equivalents, and short-term investments as of June 30, 2026, will enable it to fund its operating expenses and capital expenditure requirements into the second half of 2029.

More on Rapport Therapeutics

Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha’s Quant Rating on Rapport Therapeutics
Historical earnings data for Rapport Therapeutics
Financial information for Rapport Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。